AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Medical Mkting Int'l - Portfolio Update.
(From AFX CNF)
RNS Number:0868S Medical Marketing Int'l Group PLC 01 March 2007 Medical Marketing International Group plc ("MMI" or the "Company") Update for MMI's ruthenium chemotherapy portfolio March 1st 2007. Medical Marketing International Group plc (the "Company") (AIM: MMG) the pharmaceutical company focused on the development of drugs for cancer and infectious diseases, today releases a development update for its portfolio of ruthenium-based cancer chemotherapy compounds. a A second generation of ruthenium compounds has been identified, with those characterised showing equipotency with our existing lead candidates. a First generation compounds 4403 and 4417 …
-
- Medical Marketing International Group plc release: Investment in Genvax Ltd.
-
News wire article from: Chemical Business Newsbase
October 30, 2008
700+ words
-
- Talks between Roche Products and MMI Group called off.(Medical Marketing...
-
Newspaper article from: M2 Europharma
August 30, 2002
700+ words
-
- Medical Marketing to get US patent for its ruthenium cancer therapy portfolio.
-
News wire article from: Europe Intelligence Wire
March 28, 2007
700+ words
-
- Medical Marketing makes progress in cancer vaccines, says focused on value.
-
News wire article from: Europe Intelligence Wire
September 17, 2008
700+ words
-
- Medical Marketing says Prudential raises stake.
-
News wire article from: Europe Intelligence Wire
August 7, 2008
700+ words
